HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea
· Delayed Price · Currency is KRW 20,500
+100 (0.49%)
May 13, 2025, 3:30 PM KST
-32.57% (1Y)
| Market Cap | 287.87B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 609.04 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 91,694 |
| Average Volume | 153,175 |
| Open | 20,400 |
| Previous Close | 20,400 |
| Day's Range | 20,250 - 21,000 |
| 52-Week Range | 15,150 - 33,900 |
| Beta | 0.33 |
| RSI | 50.35 |
| Earnings Date | n/a |